Previsioni di mercato per la scoperta di anticorpi in Europa fino al 2030 - Analisi regionale - per tipo di anticorpo (anticorpi monoclonali, anticorpi policlonali e altri), natura (umano e umanizzato, chimerico e murino), servizi (Phage Display, ibridoma, animale transgenico, cellula singola e Yeast Display) e utente finale (aziende farmaceutiche e biotecnologiche, laboratori di ricerca e altri)
La crescente incidenza del cancro guida il mercato europeo della scoperta di anticorpi
Secondo le stime del Global Cancer Observatory (GLOBOCAN) pubblicate nel 2020, si sono verificati 19,3 milioni di casi di cancro in tutto il mondo. Entro gennaio 2030, si stima che la popolazione di sopravvissuti al cancro raggiungerà i 22,1 milioni, il che può essere principalmente associato all\'invecchiamento della popolazione. Polmone, seno, colon-retto, prostata e seno sono tra i tipi di cancro più comunemente segnalati. La crescente incidenza del cancro ha sollevato preoccupazioni in tutto il mondo. Di seguito è riportato l\'elenco dei casi di cancro più comuni segnalati in tutto il mondo nel 2020.
Nuovi casi di cancro nel mondo, nel 2020
Sr. No.
Tipo di cancro
Numero di casi (milioni)
1
Stomaco
1,09
2
Pelle (non melanoma)
1,2
3
Prostata
1,41
4
Colon e retto
1,93
5
Polmone
2,21
6
Seno
2,26
Fonte: Organizzazione mondiale della sanità, febbraio 2020
Il cancro è ormai una malattia legata allo stile di vita, comunemente riscontrata tra le persone con cattive abitudini alimentari e coloro che non svolgono molte attività fisiche. Il consumo frequente di alcol e tabacco aumenta il rischio di sviluppare il cancro. Le malattie infettive croniche nei paesi a basso e medio reddito possono aggravare ulteriormente i fattori di rischio del cancro. Un aumento dell\'incidenza del cancro indica la necessità di trattamenti innovativi contro il cancro. Gli anticorpi monoclonali rappresentano una promettente classe di agenti antitumorali mirati che migliorano la capacità naturale del sistema immunitario di sopprimere l\'attività delle cellule tumorali ed eliminare le cellule tumorali. Anche i coniugati anticorpo-farmaco (ADC) hanno mostrato risultati promettenti nel trattamento del cancro. Inoltre, i progressi nella moderna biotecnologia consentono a ricercatori e aziende di fornire nuovi anticorpi ben progettati, aprendo la strada a trattamenti di successo di vari tipi di cancro. Pertanto, la crescente incidenza di diversi tipi di cancro stimola la crescita del mercato della scoperta di anticorpi.
Panoramica del mercato europeo della scoperta di anticorpi
Il mercato europeo della scoperta di anticorpi è segmentato in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa. La regione detiene una quota significativa del mercato globale. Si prevede che registrerà un robusto tasso di crescita nei prossimi anni a causa del crescente utilizzo di anticorpi monoclonali nelle applicazioni di ricerca e sviluppo, nelle terapie contro il cancro e nella gestione dei disturbi immunologici. Inoltre, si prevede che la crescente necessità di sistemi di gestione dei dati dei pazienti, la prevalenza di malattie croniche e le iniziative governative per l\'implementazione di servizi sugli anticorpi forniranno opportunità di crescita per il mercato della scoperta di anticorpi in paesi come Francia, Italia e Spagna.
Fatturato e previsioni del mercato della scoperta di anticorpi in Europa fino al 2030 (miliardi di $ USA)
Segmentazione del mercato della scoperta di anticorpi in Europa
Il mercato della scoperta di anticorpi in Europa è suddiviso in tipo di anticorpo, natura, servizi, utente finale e paese.
In base al tipo di anticorpo, il mercato della scoperta di anticorpi in Europa è suddiviso in anticorpi monoclonali, anticorpi policlonali e altri. Il segmento degli anticorpi monoclonali ha detenuto la quota di mercato della scoperta di anticorpi in Europa più grande nel 2022.
In termini di natura, il mercato della scoperta di anticorpi in Europa è suddiviso in umano e umanizzato, chimerico e murino. Il segmento umano e umanizzato ha detenuto la quota di mercato della scoperta di anticorpi in Europa più grande nel 2022.
In base ai servizi, il mercato europeo della scoperta di anticorpi è suddiviso in phage display, ibridoma, animale transgenico, cellula singola e lievito display. Il segmento phage display ha detenuto la quota di mercato più grande in Europa nella scoperta di anticorpi nel 2022.
In base all\'utente finale, il mercato europeo della scoperta di anticorpi è suddiviso in aziende farmaceutiche e biotecnologiche, laboratori di ricerca e altri. Il segmento delle aziende farmaceutiche e biotecnologiche ha detenuto la quota di mercato più grande in Europa nella scoperta di anticorpi nel 2022.
In base al paese, il mercato europeo della scoperta di anticorpi è suddiviso in Germania, Regno Unito, Francia, Italia, Spagna e resto d\'Europa. La Germania ha dominato la quota di mercato europea della scoperta di anticorpi nel 2022.
Charles River Laboratories International Inc, Creative Biolabs Inc, Evotec SE, Sartorius AG, Aragen Life Sciences Ltd, Twist Bioscience Corp e Biocytogen Pharmaceuticals Beijing Co Ltd. sono alcune delle aziende leader che operano nel mercato europeo della scoperta di anticorpi.
TABLE OF CONTENTS
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Europe Antibody Discovery Market - Key Market Dynamics
4.1 Market Drivers
4.1.1 Increasing Investments in Research & Development
4.1.2 Rising Incidence of Cancer
4.2 Market Restraints
4.2.1 High Cost of Production
4.3 Market Opportunities
4.3.1 Proliferation of Biotechnology Industry in Developing Regions
4.4 Future Trends
4.4.1 Developments for Custom Antibodies
4.5 Impact of Drivers and Restraints:
5. Antibody Discovery Market - Europe Market Analysis
5.1 Europe Antibody Discovery Market Revenue (US$ Million), 2020-2030
6. Europe Antibody Discovery Market Analysis - by Antibody Type
6.1 Overview
6.2 Monoclonal Antibodies
6.2.1 Overview
6.2.2 Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.3 Polyclonal Antibodies
6.3.1 Overview
6.3.2 Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
6.4 Others
6.4.1 Overview
6.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7. Europe Antibody Discovery Market Analysis - by Nature
7.1 Overview
7.2 Human and Humanized
7.2.1 Overview
7.2.2 Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.3 Chimeric
7.3.1 Overview
7.3.2 Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
7.4 Murine
7.4.1 Overview
7.4.2 Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8. Europe Antibody Discovery Market Analysis - by Services
8.1 Overview
8.2 Phage Display
8.2.1 Overview
8.2.2 Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.3 Hybridoma
8.3.1 Overview
8.3.2 Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.4 Transgenic Animal
8.4.1 Overview
8.4.2 Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.5 Yeast Display
8.5.1 Overview
8.5.2 Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
8.6 Single Cell
8.6.1 Overview
8.6.2 Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9. Europe Antibody Discovery Market Analysis - by End User
9.1 Overview
9.2 Pharmaceutical and Biotechnology Companies
9.2.1 Overview
9.2.2 Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.3 Research Laboratories
9.3.1 Overview
9.3.2 Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
9.4 Others
9.4.1 Overview
9.4.2 Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10. Europe Antibody Discovery Market - Country Analysis
10.1 Europe Antibody Discovery Market, Revenue and Forecast to 2030
10.1.1 Europe: Antibody Discovery Market - Revenue and Forecast Analysis - by Country
10.1.1.1 UK
10.1.1.1.1 Overview
10.1.1.1.2 UK: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.1.3 UK: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.1.4 UK: Antibody Discovery Market Breakdown, by Nature
10.1.1.1.5 UK: Antibody Discovery Market Breakdown, by Services
10.1.1.1.6 UK: Antibody Discovery Market Breakdown, by End User
10.1.1.2 Germany
10.1.1.2.1 Overview
10.1.1.2.2 Germany: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.2.3 Germany: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.2.4 Germany: Antibody Discovery Market Breakdown, by Nature
10.1.1.2.5 Germany: Antibody Discovery Market Breakdown, by Services
10.1.1.2.6 Germany: Antibody Discovery Market Breakdown, by End User
10.1.1.3 France
10.1.1.3.1 Overview
10.1.1.3.2 France: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.3.3 France: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.3.4 France: Antibody Discovery Market Breakdown, by Nature
10.1.1.3.5 France: Antibody Discovery Market Breakdown, by Services
10.1.1.3.6 France: Antibody Discovery Market Breakdown, by End User
10.1.1.4 Italy
10.1.1.4.1 Overview
10.1.1.4.2 Italy: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.4.3 Italy: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.4.4 Italy: Antibody Discovery Market Breakdown, by Nature
10.1.1.4.5 Italy: Antibody Discovery Market Breakdown, by Services
10.1.1.4.6 Italy: Antibody Discovery Market Breakdown, by End User
10.1.1.5 Spain
10.1.1.5.1 Overview
10.1.1.5.2 Spain: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.5.3 Spain: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.5.4 Spain: Antibody Discovery Market Breakdown, by Nature
10.1.1.5.5 Spain: Antibody Discovery Market Breakdown, by Services
10.1.1.5.6 Spain: Antibody Discovery Market Breakdown, by End User
10.1.1.6 Rest of Europe
10.1.1.6.1 Overview
10.1.1.6.2 Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
10.1.1.6.3 Rest of Europe: Antibody Discovery Market Breakdown, by Antibody Type
10.1.1.6.4 Rest of Europe: Antibody Discovery Market Breakdown, by Nature
10.1.1.6.5 Rest of Europe: Antibody Discovery Market Breakdown, by Services
10.1.1.6.6 Rest of Europe: Antibody Discovery Market Breakdown, by End User
11. Antibody Discovery Market-Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Antibody Discovery Market
11.3 Inorganic Growth Strategies
11.3.1 Overview
11.4 Organic Growth Strategies
11.4.1 Overview
12. Company Profiles
12.1 Charles River Laboratories International Inc
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 Creative Biolabs Inc
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Evotec SE
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Sartorius AG
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Aragen Life Sciences Ltd
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Twist Bioscience Corp
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Biocytogen Pharmaceuticals Beijing Co Ltd
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
List of Tables
Table 1. Europe Antibody Discovery Market Segmentation
Table 2. New Cancer Cases Worldwide, in 2020
Table 3. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 4. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 5. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 6. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 7. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 8. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 9. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 10. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 11. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 12. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 13. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 14. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 15. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 16. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 17. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 18. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 19. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 20. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 21. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 22. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 23. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Antibody Type
Table 24. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Nature
Table 25. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by Services
Table 26. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million) - by End User
Table 27. Recent Inorganic Growth Strategies in the Antibody Discovery Market
Table 28. Recent Organic Growth Strategies in the Antibody Discovery Market
Table 29. Glossary of Terms, Antibody Discovery Market
List of Figures
Figure 1. Europe Antibody Discovery Market Segmentation, by Country
Figure 2. Europe Antibody Discovery Market - Key Market Dynamics
Figure 3. Impact Analysis of Drivers and Restraints
Figure 4. Europe Antibody Discovery Market Revenue (US$ Million), 2020 - 2030
Figure 5. Europe Antibody Discovery Market Share (%) - by Antibody Type (2022 and 2030)
Figure 6. Monoclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 7. Polyclonal Antibodies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 8. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 9. Europe Antibody Discovery Market Share (%) - by Nature (2022 and 2030)
Figure 10. Human and Humanized: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 11. Chimeric: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 12. Murine: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 13. Europe Antibody Discovery Market Share (%) - by Services (2022 and 2030)
Figure 14. Phage Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 15. Hybridoma: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 16. Transgenic Animal: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 17. Yeast Display: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 18. Single Cell: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 19. Europe Antibody Discovery Market Share (%) - by End User (2022 and 2030)
Figure 20. Pharmaceutical and Biotechnology Companies: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 21. Research Laboratories: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 22. Others: Europe Antibody Discovery Market - Revenue and Forecast to 2030 (US$ Million)
Figure 23. Europe: Antibody Discovery Market, by Key Country - Revenue (2022) (US$ Million)
Figure 24. Europe: Antibody Discovery Market Breakdown, by Key Countries, 2022 and 2030 (%)
Figure 25. UK: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 26. Germany: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 27. France: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 28. Italy: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 29. Spain: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 30. Rest of Europe: Antibody Discovery Market - Revenue and Forecast to 2030(US$ Million)
Figure 31. Growth Strategies in the Antibody Discovery Market
- Charles River Laboratories International Inc
- Creative Biolabs Inc
- Evotec SE
- Sartorius AG
- Aragen Life Sciences Ltd
- Twist Bioscience Corp
- Biocytogen Pharmaceuticals Beijing Co Ltd
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the Europe antibody discovery market.
- Highlights key business priorities in order to assist companies to realign their business strategies.
- The key findings and recommendations highlight crucial progressive industry trends in the Europe antibody discovery market, thereby allowing players across the value chain to develop effective long-term strategies.
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
- Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the Europe antibody discovery market, as well as those hindering it.
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution.